105,000 Shares in AdaptHealth Corp. (NASDAQ:AHCO) Bought by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. bought a new position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 105,000 shares of the company's stock, valued at approximately $1,000,000. Hussman Strategic Advisors Inc. owned about 0.08% of AdaptHealth at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in AHCO. Blue Trust Inc. lifted its holdings in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after acquiring an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after buying an additional 1,690 shares during the last quarter. Rhumbline Advisers raised its position in shares of AdaptHealth by 0.5% during the 4th quarter. Rhumbline Advisers now owns 313,110 shares of the company's stock valued at $2,981,000 after acquiring an additional 1,691 shares in the last quarter. Mutual of America Capital Management LLC lifted its position in shares of AdaptHealth by 23.8% in the 3rd quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company's stock worth $178,000 after buying an additional 3,052 shares during the last quarter. Finally, LRI Investments LLC grew its holdings in shares of AdaptHealth by 32.0% during the third quarter. LRI Investments LLC now owns 15,331 shares of the company's stock valued at $172,000 after purchasing an additional 3,713 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Stock Up 25.5 %

Shares of AHCO traded up $2.18 during midday trading on Tuesday, reaching $10.73. 6,792,093 shares of the stock were exchanged, compared to its average volume of 1,109,592. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -6.50, a P/E/G ratio of 1.08 and a beta of 1.12. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 12-month low of $7.25 and a 12-month high of $11.90. The firm has a 50 day simple moving average of $9.83 and a 200-day simple moving average of $10.19.

Analyst Upgrades and Downgrades

AHCO has been the topic of several analyst reports. Royal Bank of Canada dropped their price target on shares of AdaptHealth from $13.00 to $11.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 19th. Truist Financial cut their price objective on AdaptHealth from $13.00 to $12.00 and set a "buy" rating for the company in a research report on Friday, November 15th. Robert W. Baird decreased their target price on shares of AdaptHealth from $16.00 to $14.00 and set an "outperform" rating for the company in a report on Wednesday, November 6th. UBS Group reduced their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Canaccord Genuity Group lowered their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research note on Wednesday, November 6th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $12.20.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.